WallStreetZenWallStreetZen

NASDAQ: BEAM
Beam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Beam Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. EvansCEO2026-01-3022,094$28.27
$624.66kSell
John M. EvansCEO2026-01-302,906$29.00
$84.27kSell
John M. EvansCEO2026-01-3025,000$0.67
$16.75kBuy
John M. EvansCEO2026-01-2916,333$29.19
$476.79kSell
John M. EvansCEO2026-01-295,664$0.67
$3.79kBuy
John M. EvansCEO2026-01-298,667$29.74
$257.78kSell
John M. EvansCEO2026-01-2919,336$0.67
$12.96kBuy
Christine BellonChief Legal Officer2026-01-221,371$34.00
$46.61kSell
Bethany J. CavanaghSVP Finance and Treasurer2026-01-226,198$35.00
$216.94kSell
Bethany J. CavanaghSVP Finance and Treasurer2026-01-203,034$30.12
$91.38kSell

1 of 4

BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BEAM insiders and whales buy or sell their stock.

BEAM Shareholders

What type of owners hold Beam Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC12.29%12,467,189$348.08MInstitution
Vanguard Group Inc9.06%9,193,474$256.68MInstitution
Blackrock Inc8.33%8,450,182$235.93MInstitution
State Street Corp5.15%5,228,529$145.98MInstitution
Fmr LLC4.68%4,752,601$132.69MInsider
Sumitomo Mitsui Trust Group Inc4.35%4,409,300$123.11MInstitution
Amova Asset Management Americas Inc4.35%4,409,300$123.11MInstitution
Robert Nelsen3.48%3,535,572$98.71MInsider
Arch Venture Partners IX LLC2.91%2,949,630$82.35MInsider
Kristina Burow2.71%2,747,530$76.71MInsider

1 of 3

BEAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BEAM60.91%16.56%Net SellingNet Selling
SYRE37.61%33.26%Net SellingNet Selling
ALMS33.63%25.89%Net BuyingNet Buying
DNLI51.84%48.16%Net SellingNet Selling
VERA47.89%50.64%Net BuyingNet Buying
View Top Biotech Stocks

Beam Therapeutics Stock Ownership FAQ

Who owns Beam Therapeutics?

Beam Therapeutics (NASDAQ: BEAM) is owned by 60.91% institutional shareholders, 16.56% Beam Therapeutics insiders, and 22.52% retail investors. Fmr LLC is the largest individual Beam Therapeutics shareholder, owning 4.75M shares representing 4.68% of the company. Fmr LLC's Beam Therapeutics shares are currently valued at $130.65M.

If you're new to stock investing, here's how to buy Beam Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.